Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort (2019)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/conf.fonc.2019.01.00003
Publication URI: http://dx.doi.org/10.3389/conf.fonc.2019.01.00003
Type: Journal Article/Review
Parent Publication: Frontiers in Oncology